<DOC>
	<DOCNO>NCT02595749</DOCNO>
	<brief_summary>Socioemotional processing dysfunction ( i.e. , disruption affective , cognitive , neural process encode , interpret , respond socially emotionally relevant stimulus ) implicate tobacco smoking relapse , however potential target medication development systematically examine . Evidence animal human laboratory indicate administration intranasal oxytocin enhance socioemotional processing may efficacious treatment drug addiction , include nicotine dependence . In order evaluate potential efficacy intranasal oxytocin smoke cessation , laboratory-based proposal examine whether intranasal oxytocin attenuate smoke lapse , nicotine withdrawal , socioemotional processing disruption regular smoker follow overnight abstinence .</brief_summary>
	<brief_title>Effects Intranasal Oxytocin Cigarette Smoking</brief_title>
	<detailed_description />
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Ages 1840 Smoke &gt; = 10 cig/day past year English fluency Current DSM5 substance use disorder , exclude nicotine dependence ( minimize alcohol drug withdrawal symptom study session ) Any medical condition would increase risk study participation ( sinus infection condition block access olfactory epithelium ) Women pregnant nursing Current use psychiatric medication Breath Carbon Monoxide ( CO ) level &lt; 10ppm measure study intake ( exclude individual overreport smoke order participate study ) Planning quit reduce smoke next 30 day Current regular use nicotine product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>